Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to...
86 insider purchases on record · latest filing 2025-08-25.
Insiders have also filed 274 sale transactions at CERS.